Now sees FY sales up 19-27% at same forex (Il Sole 24 Ore Radiocor) - Copenhagen, 02 May - For 2024, Novo Nordisk now expects sales growth to be 19-27% at constant exchange rates, and operating profit growth is now expected to be 22-30% on currency-neutral basis.

Growth reported in Danish crowns is now expected to be in line with constant exchange rate growth for both sales and operating profit.

AAA-Web

(RADIOCOR) 02-05-24 08:01:28 (0082) 5 NNNN